Hochster, Howard <br/><br/>
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.  [electronic resource] 

 -  Gynecologic oncology  Mar 2008 
 - 500-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2007.11.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Papillary--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Neoplasm Staging<br/>Organoplatinum Compounds--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Oxaliplatin<br/>Peritoneal Neoplasms--drug therapy<br/>Topotecan--administration & dosage<br/>Treatment Outcome